Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 05, 2022

SELL
$126.46 - $235.05 $300,216 - $558,008
-2,374 Closed
0 $0
Q4 2021

Jan 05, 2022

BUY
$225.82 - $368.51 $42,905 - $70,016
190 Added 8.7%
2,374 $603,000
Q3 2021

Oct 05, 2021

BUY
$221.9 - $484.47 $484,629 - $1.06 Million
2,184 New
2,184 $840,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Fulton Bank, N.A. Portfolio

Follow Fulton Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.